Mutations in Steroid 21-Hydroxylase (CYP21)
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The inherited inability to synthesize cortisol is termed congenital adrenal hyperplasia. More than 90% of cases are caused by 21-hydroxylase deficiency. This syndrome is characterized by signs of androgen excess and often mineralocorticoid deficiency. Steroid 21-hydroxylase (P450c21) is a microsomal enzyme expressed in the adrenal gland that catalyzes conversion of 17-hydroxyprogesterone and progesterone to 11-deoxycortisol and deoxycorticosterone respectively. In man, this enzyme is encoded by the CYP21 (CYP21B) gene which is located in the HLA major histocompatibility complex along with a pseudogene, CYP21P (CYP21A). Mutations in CYP21 causing congenital adrenal hyperplasia are almost all generated by recombinations between CYP21 and CYP21P. These recombinations either delete CYP21 or transfer deleterious mutations from CYP21P to CYP21, a process termed apparent gene conversion. The degree of enzymatic compromise caused by each mutation is correlated with the clinical severity of the deficiency observed in patients carrying that mutation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with mild CAH have been often reported to be asymptomatic (cortisol concentrations following similar trajectories throughout the day) or with signs of androgen excess (increased ACTH, around 10-fold higher morning peak), while for patients with severe CAH excess androgen production was even more pronounced (increased ACTH, around 100-fold higher morning peak) [4, 6, 31, 32].”
In the citing paper
“Functional in vitro studies have allowed classification of CYP21A2 pathogenic variants into four groups based on residual enzymatic activity: group 0 (null, 0%), group A (<2%), group B (3-7%), and group C (20-60%), as summarized in Table 1 (18, 31, 48–50).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [50]
In the citing paper
“Most apparent point mutations in CYP21A2 are actually small gene conversion events (350, 351, 426), so that gene conversions account for about 85% of the lesions in 21-hydroxylase deficiency.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [426]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes.
Saiki, R. K., Walsh, P. S., Levenson, C. H., & Erlich, H. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6230 · Cited by 1,008
Crystal Structure of Hemoprotein Domain of P450BM-3, a Prototype for Microsomal P450's
Ravichandran, K. G., Boddupalli, S. S., Hasermann, C. A., Peterson, J. A., & Deisenhofer, J. (1993) · Science · doi:10.1126/science.8342039 · Cited by 877
Genetic disease detection and DNA amplification using cloned thermostable ligase.
Barany, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.189 · Cited by 796
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Self-citationStructure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
Self-citationHigashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Self-citationWhite, P. C., Grossberger, D., Onufer, B. J., Chaplin, D. D., New, M. I., Dupont, B., & Strominger, J. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1089 · Cited by 490
Self-citationCarroll, M. C., Campbell, R. D., & Porter, R. R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.521 · Cited by 370
Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
Bristow, J., Tee, M., Gitelman, S., Mellon, S., & Miller, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.265 · Cited by 302
Tusie-Luna, M. T., Traktman, P., & White, P. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45304-x · Cited by 254
Self-citationMutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency
Amor, M., Parker, K. L., Globerman, H., New, M. I., & White, P. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1600 · Cited by 251
Self-citationHigashi, Y., Tanae, A., Inoue, H., Hiromasa, T., & Fujii-Kuriyama, Y. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7486 · Cited by 244
Characterization of frequent deletions causing steroid 21-hydroxylase deficiency
White, P. C., Vitek, A., Dupont, B., & New, M. I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4436 · Cited by 229
Self-citationSpeiser, P. W., New, M. I., & White, P. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190104 · Cited by 205
Self-citationHigashi, Y., Hiromasa, T., Tanae, A., Miki, T., Nakura, J., Kondo, T., Ohura, T., Ogawa, E., Nakayama, K., & Fujii-Kuriyama, Y. (1991) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123433 · Cited by 201
Higashi, Y., Tanae, A., Inoue, H., & Fujii-Kuriyama, Y. (1988) · Europe PMC (PubMed Central) · Cited by 185
Tusie-Luna, M.-T., Speiser, P. W., Dumic, M., New, M. I., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-685 · Cited by 183
Self-citationRodrigues, N. R., Dunham, I., Yu, C. Y., Carroll, M. C., Porter, R. R., & Campbell, R. D. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02414.x · Cited by 182
Forest, M. G., Bétuel, H., & David, M. (1989) · Endocrine Research · doi:10.1080/07435808909039101 · Cited by 172
(1991) · Europe PMC (PubMed Central) · Cited by 164
Self-citationWedell, A., & Luthman, H. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.5.499 · Cited by 160
Wedell, A., Ritzén, E. M., Haglund-Stengler, B., & Luthman, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7232 · Cited by 150
A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency.
Chiou, S. H., Hu, M. C., & Chung, B. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39804-7 · Cited by 149
Morel, Y., André, J., Uring-Lambert, B., Hauptmann, G., Bétuel, H., Tossi, M., Forest, M. G., David, M., Bertrand, J., & Miller, W. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113914 · Cited by 134
Nonsense mutation causing steroid 21-hydroxylase deficiency
Globerman, H., Amor, M., Parker, K. L., New, M. I., & White, P. C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113562 · Cited by 130
Self-citationSPEISER, P. W., LAFORGIA, N., KATO, K., PAREIRA, J., KHAN, R., YANG, S. Y., WHORWOOD, C., WHITE, P. C., ELIAS, S., SCHRIOCK, E., et al. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-838 · Cited by 128
Self-citationHelmberg, A., Tusie-Luna, M. T., Tabarelli, M., Kofler, R., & White, P. C. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.8.1406709 · Cited by 123
Self-citationCollier, S., Sinnott, P. J., Dyer, P. A., Price, D. A., Harris, R., & Strachan, T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03520.x · Cited by 119
Collier, S., Tassabehji, M., & Strachan, T. (1993) · Nature Genetics · doi:10.1038/ng0393-260 · Cited by 91
Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency
Owerbach, D., Sherman, L., Ballard, A. L., & Azziz, R. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.8.1406699 · Cited by 91
Abundant adrenal-specific transcription of the human P450c21A “pseudogene.”
Bristow, J., Gitelman, S. E., Tee, M. K., Staels, B., & Miller, W. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31473-x · Cited by 84
Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene
Wedell, A., & Luthman, H. (1993) · Human Genetics · doi:10.1007/bf00218263 · Cited by 81
Wu, D. A., & Chung, B. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115334 · Cited by 80
Tajima, T., Fujieda, K., Nakayama, K., & Fujii-Kuriyama, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116820 · Cited by 78
Owerbach, D., Crawford, Y. M., & Draznin, M. B. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-1-125 · Cited by 74
Sinnott, P., Collier, S., Costigan, C., Dyer, P. A., Harris, R., & Strachan, T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2107 · Cited by 67
Speiser, P., White, P., Dupont, J., Zhu, D., Mercado, A. B., & New, M. I. (1994) · Human Genetics · doi:10.1007/bf00201668 · Cited by 54
Self-citationTajima, T., Fujieda, K., & Fujii-Kuriyama, Y. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.1.8325964 · Cited by 38
Genetics of Steroid 21-Hydroxylase Deficiency
White, P. C. (1987) · Elsevier eBooks · doi:10.1016/b978-0-12-571143-2.50014-9 · Cited by 18
Self-citationOwerbach, D., Draznin, M. B., Carpenter, R., & Greenberg, F. (1992) · Human Genetics · doi:10.1007/bf00207055 · Cited by 14
Research works printed but not linked: 7
- Helmherg, 1992, Mol Endocrinol, 6, 1318
- Higashi, 1988a, Am J Hum Genet, 42, 17
- Mornet, 1991, Am J Hum Genet, 48, 79
- Owerbach, 1992b, Mol Endocrinol, 6, 1211
- Speiser, 1985, Am J Hum Genet, 37, 650
- Tajima, 1993a, J Clin Endocrinol Metab, 77, 86
- White, 1987, Recent Prog Hormone Res, 43, 305
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Guengerich, F. P. (1995) · Cytochrome P450 · doi:10.1007/978-1-4757-2391-5_14 · Cited by 728
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
“The 10 previously described major mutations, which apparently are generated by recombination between the active CYP21 gene and the corresponding pseudogene (2, 8), were also found to dominate the mutation spectrum of our cohort.”
BackgroundKitanaka, S., Takeyama, K.-I., Murayama, A., Sato, T., Okumura, K., Nogami, M., Hasegawa, Y., Niimi, H., Yanagisawa, J., Tanaka, T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381004 · Cited by 387
Metadata
- Authors
- White, P. C., Tusie-Luna, M.-T., New, M. I., & Speiser, P. W.
- Affiliations
- Cornell University (US)
- Northwell Health (US)
- Corresponding author
- Speiser, Phyllis W.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 1994
- Volume
- 3
- Issue
- 4
- Pages
- 373-378
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2065606880
- Semantic Scholar
- c588b6b4ce8a7f68cf106bc55959c99100c0766e
- Cited by
- 129
- References
- 42
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 7913 d)
- Locations
- Human Mutation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- CYP21, 21-hydroxylase, congenital adrenal hyperplasia, 21-hydroxylase deficiency, HLA class II, cortisol production, hyperandrogenism, mineralocorticoid deficiency, clinical severity
- MeSH terms
- Adrenal Hyperplasia, Congenital, Chromosomes, Human, Pair 6, Gene Conversion, Genotype, Humans, Mutation, Phenotype, Polymorphism, Genetic, Pseudogenes, Steroid 21-Hydroxylase, Point Mutation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.